SCCP on tooth whitener studies
This article was originally published in The Tan Sheet
Executive Summary
Guidance on product application, end points, size and definition of study populations, including subgroup, and study duration is included in the European Commission's Scientific Committee on Consumer Products' recently published "Guidance Document on Epidemiological and Clinical Studies on Tooth Whitening Products." The 1guidance responds to a March 2005 SCCP meeting in which the committee observed that there is an "absence of good data and long-term epidemiology studies that assess the possible adverse effects [of tooth whiteners] within the oral cavity" (2"The Tan Sheet" April 4, 2005, p. 16). Parameters such as the separate evaluation of hard and soft tissue effects and the evaluation of age groups since "differences in the degrees of mineralization of dental hard tissue may affect the treatment outcome," are also addressed...
You may also be interested in...
SCCP Upholds Opinion On Tooth Whiteners With Hydrogen Peroxide
Adequate data do not exist to support the safety of tooth-whitening products containing up to 6% hydrogen peroxide for over-the-counter use, the European Commission Scientific Committee on Consumer Products concludes in a recent opinion
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.